First-in-Human CAR-T test for tough cancers halted early
NCT ID NCT07108140
Summary
This was a very early, small pilot study to test the safety of a new CAR-T cell therapy for patients with advanced solid tumors that have a specific protein called ALPP. The study involved only 5 patients who had already tried other treatments without success. The main goal was to find the highest safe dose and check for side effects, but the trial was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Jinling Hospital
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.